GRIN2D and schizophrenia: These studies suggest the GluN2D subunit expressing NMDA receptors are critical in mediating many of the effects of NMDAR antagonists, like ketamine, on the behaviour and electrophysiology that is relevant to schizophrenia, and thus may, in turn, suggest a role for the GluN2D subunit in the development of schizophrenia.